BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4041343)

  • 1. The influence of diflunisal on the pharmacokinetics of oxazepam.
    van Hecken AM; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1985 Sep; 20(3):225-34. PubMed ID: 4041343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between diflunisal and warfarin.
    Serlin MJ; Mossman S; Sibeon RG; Tempero KF; Breckenridge AM
    Clin Pharmacol Ther; 1980 Oct; 28(4):493-8. PubMed ID: 7408409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
    Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.
    Eriksson LO; Wåhlin-Boll E; Liedholm H; Seideman P; Melander A
    Eur J Clin Pharmacol; 1989; 37(1):7-15. PubMed ID: 2591467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.
    Loewen GR; Herman RJ; Ross SG; Verbeeck RK
    Br J Clin Pharmacol; 1988 Jul; 26(1):31-9. PubMed ID: 3203058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.
    Macdonald JI; Wallace SM; Herman RJ; Verbeeck RK
    Eur J Clin Pharmacol; 1995; 47(6):519-23. PubMed ID: 7768255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease.
    Busch U; Molzahn M; Bozler G; Koss FW
    Arzneimittelforschung; 1981; 31(9):1507-11. PubMed ID: 7197965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers.
    Addison RS; Parker-Scott SL; Eadie MJ; Hooper WD; Dickinson RG
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):715-21. PubMed ID: 11214782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of multiple dosage on the kinetics of glucuronidation and sulphation of diflunisal in man.
    Verbeeck RK; Loewen GR; MacDonald JI; Herman RJ
    Br J Clin Pharmacol; 1990 Apr; 29(4):381-9. PubMed ID: 2328191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.
    Patel M; Tang BK; Grant DM; Kalow W
    Pharmacogenetics; 1995 Oct; 5(5):287-97. PubMed ID: 8563769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats.
    Lin JH; Yeh KC; Duggan DE
    Drug Metab Dispos; 1985; 13(3):321-6. PubMed ID: 2861991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pentobarbital on the formation of diastereomeric oxazepam glucuronides in man: analysis by high performance liquid chromatography.
    Seideman P; Ericsson O; Gröningsson K; von Bahr C
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):200-4. PubMed ID: 7336978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein binding of oxazepam and its glucuronide conjugates to human albumin.
    Boudinot FD; Homon CA; Jusko WJ; Ruelius HW
    Biochem Pharmacol; 1985 Jun; 34(12):2115-21. PubMed ID: 4004929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative versus conjugative biotransformation of temazepam.
    Locniskar A; Greenblatt DJ
    Biopharm Drug Dispos; 1990; 11(6):499-506. PubMed ID: 2207300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the renal excretion of the acyl glucuronide, phenolic glucuronide and sulphate conjugates of diflunisal.
    Dickinson RG; King AR; McKinnon GE; Hooper WD; Eadie MJ; Herkes GK
    Br J Clin Pharmacol; 1993 Jun; 35(6):609-13. PubMed ID: 8329288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of alkaline diuresis to enhance diflunisal elimination.
    Balali-Mood M; Prescott LF
    Br J Clin Pharmacol; 1980 Aug; 10(2):163-5. PubMed ID: 7426277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
    Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cimetidine on the pharmacokinetics of desmethyldiazepam and oxazepam.
    Klotz U; Reimann I
    Eur J Clin Pharmacol; 1980 Nov; 18(6):517-20. PubMed ID: 6780369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.